A nurse is caring for a client who recently gave birth. The nurse notices the newborn is displaying manifestations of opioid withdrawal. The nurse should recognize the newborn's manifestations as signs of which of the following conditions?

B. Dissociative identity disorder (DID) can affect individuals of any age, including children. While treatment approaches may vary depending on the age of the individual and their specific needs, one aspect that remains consistent across age groups is the importance of assessing for thoughts of self-harm or suicidal ideation.

A. Nursing interventions for dissociative identity disorder (DID) can be diverse and tailored to the individual needs of the patient, regardless of age. While managing DID in children may present some unique challenges compared to adults, it doesn't mean that nursing interventions are limited. This option may not provide helpful information to the guardian seeking guidance.

C. Treatment outcomes for DID can vary widely depending on various factors, including the severity of symptoms, the presence of comorbid conditions, the quality of therapeutic interventions, and the individual's support system. While some older individuals may respond well to treatment, age alone is not a determining factor in treatment outcomes.

D. Dissociative identity disorder can occur in both children and adults, and psychiatric medication may be prescribed to individuals of any age depending on the severity of symptoms and individual treatment plans. Medication is often used to manage comorbid conditions such as depression, anxiety, or mood disorders that commonly co- occur with DID.

C. Psychiatric pharmacogenomic testing involves analyzing an individual's genetic makeup to predict their response to psychiatric medications. This testing provides healthcare providers with information about how an individual's genetic variations may impact their metabolism of medications.

A. Psychiatric pharmacogenomic testing can inform treatment decisions but it does not determine the likelihood of a cure. Mental illness is complex and often requires multimodal treatment approaches beyond medication alone.

B. Pharmacogenomic testing can provide information about how an individual's genetics may interact with specific medications but it primarily focuses on identifying which medications are likely to be most effective for the individual, rather than interactions between medications.

D. Psychiatric pharmacogenomic testing does not determine the cause of mental illness. Mental illnesses are multifactorial and have complex etiologies involving genetic, biological, environmental, and psychosocial factors.